Ex parte SABB - Page 2




          Appeal No. 94-2100                                                           
          Application 07/902,109                                                       


          is illustrative of the subject matter on appeal and reads as                 
          follows:                                                                     


               1.  A compound of the formula I                                         














          wherein                                                                      
          R  is H, alkyl or cycloalkyl of 1 to 6 carbon atoms;1                                                                           
          R  is H, alkyl of 1 to 6 carbon atoms, cyano, halo, nitro, amino2                                                                           
               or mono or dialkylamino in which the alkyl groups have 1 to             
               6 carbon atoms;                                                         
          R  is H or alkyl of 1 to 6 carbon atoms;3                                                                           
          n is 1 to 5                                                                  
               4      5                                                                
          and R  and R  taken with the nitrogen atom to which they are                 
          attached are a piperazin-1-yl moiety in the 4-position of which              
          is H, alkyl of 1 to 6 carbon atoms or unsubstituted or                       
          substituted pyrimidinyl, pyridinyl, or pyrazinyl wherein the                 
          substituents are alkyl of 1 to 6 carbon atoms, alkoxyl of 1 to 6             
          carbon atoms, halo, cyano, nitro or trifluoromethyl or a                     
          pharmaceutically acceptable salt, hydrate or solvate thereof.                
                                           2                                           





Page:  Previous  1  2  3  4  5  6  7  8  9  Next 

Last modified: November 3, 2007